David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$410M |
| 2 |
Chevron
CVX
|
+$400M |
| 3 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$381M |
| 4 |
Williams Companies
WMB
|
+$300M |
| 5 |
SLB Ltd
SLB
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$358M |
| 3 |
Biogen
BIIB
|
+$306M |
| 4 |
YHOO
Yahoo Inc
YHOO
|
+$298M |
| 5 |
Bausch Health
BHC
|
+$298M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 11.89% |
| 2 | Technology | 10.04% |
| 3 | Healthcare | 9.38% |
| 4 | Consumer Discretionary | 8.99% |
| 5 | Industrials | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Encompass Health
EHC
$11.9B
| $7.83M | 0.01% |
213,816
-103,282
| -33% | -$3.68M |
|
|
XLNX
1152
CALL
DELISTED
Xilinx Inc
XLNX
| $7.83M | 0.01% |
177,400
+17,900
| +11% | +$807K |
|
|
POM
1153
DELISTED
PEPCO HOLDINGS, INC.
POM
| $7.83M | 0.01% |
+290,628
| New | +$7.72M |
|
1154
Live Nation Entertainment
LYV
$43.5B
| $7.81M | 0.01% |
283,996
-27,761
| -9% | -$758K |
|
1155
Tesla
TSLA
$1.38T
| $7.76M | 0.01% |
434,130
+332,235
| +326% | +$5.25M |
|
|
LQ
1156
DELISTED
La Quinta Holdings Inc.
LQ
| $7.76M | 0.01% |
339,706
-43,660
| -11% | -$1.04M |
|
1157
CALL
Thermo Fisher Scientific
TMO
$232B
| $7.75M | 0.01% |
59,700
| – | – |
|
1158
CALL
Synaptics
SYNA
$3.71B
| $7.75M | 0.01% |
89,300
+79,300
| +793% | +$7.24M |
|
1159
CALL
Helmerich & Payne
HP
$4.21B
| $7.7M | 0.01% |
109,400
| – | – |
|
1160
Zebra Technologies
ZBRA
$17.1B
| $7.7M | 0.01% |
69,324
-9,379
| -12% | -$973K |
|
1161
CALL
Expedia Group
EXPE
$40.6B
| $7.69M | 0.01% |
70,300
| – | – |
|
1162
Kinross Gold
KGC
$39.7B
| $7.69M | 0.01% |
3,313,106
-509,071
| -13% | -$1.21M |
|
|
DHC
1163
Diversified Healthcare Trust
DHC
$1.96B
| $7.67M | 0.01% |
+441,228
| New | +$8.74M |
|
|
PCP
1164
PUT
DELISTED
PRECISION CASTPARTS CORP
PCP
| $7.67M | 0.01% |
+38,400
| New | +$8.06M |
|
1165
PUT
Stratasys
SSYS
$693M
| $7.66M | 0.01% |
219,300
+100,500
| +85% | +$4.22M |
|
|
1166
PUT
Expedia Group
EXPE
$40.6B
| $7.66M | 0.01% |
70,000
+10,000
| +17% | +$1.03M |
|
1167
Enovis
ENOV
$1.48B
| $7.64M | 0.01% |
96,178
+31,025
| +48% | +$2.63M |
|
|
BITA
1168
DELISTED
Bitauto Holdings Limited
BITA
| $7.63M | 0.01% |
149,552
+138,404
| +1,242% | +$8.13M |
|
1169
CALL
Bristol-Myers Squibb
BMY
$139B
| $7.63M | 0.01% |
114,700
-87,500
| -43% | -$5.77M |
|
1170
Insperity
NSP
$2B
| $7.63M | 0.01% |
299,774
+61,852
| +26% | +$1.61M |
|
1171
CALL
Clorox
CLX
$12.7B
| $7.63M | 0.01% |
73,300
| – | – |
|
|
NVO
1172
Novo Nordisk
NVO
$215B
| $7.61M | 0.01% |
278,042
+202,406
| +268% | +$5.69M |
|
1173
Jefferies Financial Group
JEF
$12.1B
| $7.56M | 0.01% |
347,816
-692,950
| -67% | -$14.8M |
|
1174
CALL
General Motors
GM
$75.3B
| $7.54M | 0.01% |
226,400
-383,800
| -63% | -$13.7M |
|
1175
CALL
PNC Financial Services
PNC
$97.4B
| $7.54M | 0.01% |
78,800
| – | – |
|
Similar funds
David Shaw's Q2 2015 Portfolio in Review
As of Q2 2015, David Shaw held 4,083 positions worth $67.1B, up 2.8% from $65.3B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw's Q2 2015 filing shows 504 new, 1,541 increased, 1,229 reduced and 364 closed positions. Its largest new stake was State Street Energy Select Sector SPDR ETF: 3,541,400 shares worth $133M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $479M.
By sector, the portfolio is most concentrated in Energy at 12% of assets, up from 10% a quarter earlier, followed by Technology and Healthcare.
- David Shaw's largest Q2 2015 buy was State Street Energy Select Sector SPDR ETF: 3,541,400 shares worth $133M.
- David Shaw added most to Gilead Sciences in Q2 2015, an estimated $410M increase.
- David Shaw's biggest Q2 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $479M.
- David Shaw fully exited TRW AUTOMOTIVE HOLDINGS CORP in Q2 2015, selling an estimated $164M.
- David Shaw's ten largest holdings make up 11% of its $67.1B portfolio in Q2 2015.
- David Shaw opened 504 new positions and closed 364 in Q2 2015.
- David Shaw's portfolio value rose 2.8% quarter-over-quarter to $67.1B.
Based on D.E. Shaw & Co's 13F filing for Q2 2015, filed 14 Aug 2015.